Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging -: Relation to clinical characteristics in subgroups of patients with multiple sclerosis

被引:104
作者
van Walderveen, MAA
Lycklama à Nijeholt, GJ
Adèr, HJ
Jongen, PJH
Polman, CH
Castelijns, JA
Barkhof, F
机构
[1] Free Univ Amsterdam Hosp, Magnet Resonance Ctr Multiple Sclerosis Res, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Radiol, NL-1007 MB Amsterdam, Netherlands
[3] Free Univ Amsterdam Hosp, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[4] Free Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam, Netherlands
[5] Stichting Multiple Sclerose Ctr, Nijmegen, Netherlands
关键词
D O I
10.1001/archneur.58.1.76
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Context: Hypointense lesions on T1-weighted spin-echo magnetic resonance images (T1 lesions) represent destructive multiple sclerosis (MS) lesions, consisting of axonal loss and matrix destruction. These lesions are being used as a secondary outcome measure in phase III clinical trials. Clinical determinants of T1 lesions may differ between subgroups of patients with MS and subsequently may have implications for the selection of patients for clinical trials. Objective: To determine if clinical characteristics of patients with MS are related to T1 lesion volume. Design: A survey of 138 patients with MS (52 with relapsing-remitting MS, 44 with secondary progressive MS, and 42 with primary progressive MS). Setting: The Magnetic Resonance Center for Multiple Sclerosis Research, University Hospital "Vrije Universiteit," Amsterdam, the Netherlands. Main Outcome Measures: Type of MS, Expanded Disability) Status Scale (EDSS) score, sex, age at first symptoms, and T1 lesion volume. Results: Patients with secondary progressive MS have the highest T1 lesion volume, patients with relapsing-remitting MS have a lower T1/T2 ratio than patients with secondary progressive MS and patients with primary progressive MS. In patients with relapsing-remitting MS and secondary progressive MS, T1 lesion volume relates to disease duration and EDSS score, while in patients with primary progressive MS sex is important. A trend toward higher T1 lesion volume was shown for male patients with primary progressive MS when compared with female patients with primary progressive MS (1.0 cm(3) vs 0.3 cm(3), P=.03); a trend toward higher T1 lesion volume was found with age at onset in patients with relapsing-remitting MS and in patients with primary progressive MS. Conclusions: In patients with MS different clinical characteristics associate with T1 lesion volume, suggesting a more destructive type of lesions in certain subgroups. A possible sex difference in (destructive) lesion development on magnetic resonance imaging should be evaluated in more detail, preferably in a cohort.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 45 条
[1]   Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis [J].
Bansil, S ;
Lee, HJ ;
Jindal, S ;
Holtz, CR ;
Cook, SD .
ACTA NEUROLOGICA SCANDINAVICA, 1999, 99 (02) :91-94
[2]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[3]   COURSE AND PROGNOSIS OF MULTIPLE-SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA-PROCESSING OF 349 PATIENTS [J].
CONFAVREUX, C ;
AIMARD, G ;
DEVIC, M .
BRAIN, 1980, 103 (JUN) :281-300
[4]   Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss [J].
Davie, CA ;
Barker, GJ ;
Webb, S ;
Tofts, PS ;
Thompson, AJ ;
Harding, AE ;
McDonald, WI ;
Miller, DH .
BRAIN, 1995, 118 :1583-1592
[5]   Imaging axonal damage of normal-appearing white matter in multiple sclerosis [J].
Fu, L ;
Matthews, PM ;
De Stefano, N ;
Worsley, KJ ;
Narayanan, S ;
Francis, GS ;
Antel, JP ;
Wolfson, C ;
Arnold, DL .
BRAIN, 1998, 121 :103-113
[6]   MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis [J].
Giugni, E ;
Pozzilli, C ;
Bastianello, S ;
Gasperini, C ;
Paolillo, A ;
Koudriavtseva, T ;
Frontoni, M ;
Farina, D ;
Bozzao, L .
MULTIPLE SCLEROSIS, 1997, 3 (04) :221-225
[7]   Correlations between clinical and MRI involvement in multiple sclerosis:: assessment using T1, T2 and MT histograms [J].
Iannucci, G ;
Minicucci, L ;
Rodegher, M ;
Sormani, MP ;
Comi, G ;
Filippi, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (02) :121-129
[8]  
KIDD D, 1993, ANN NEUROL, V34, P308
[9]   Estriol ameliorates autoimmune demyelinating disease - Implications for multiple sclerosis [J].
Kim, S ;
Liva, SM ;
Dalal, MA ;
Verity, MA ;
Voskuhl, RR .
NEUROLOGY, 1999, 52 (06) :1230-1238
[10]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444